Corporate Updates
Kalbe Farma (KLBF IJ): Stability persists despite hurdles
Kalbe Farma (KLBF IJ)
Not rated
Analyst: Laras Nadira
Stability persists despite hurdles
• GPM continue to slip
• New revenue stream from Aventis
• Updates on specialty medical products
• Valuation